Wynnewood, PA, United States of America

Roberta Lamb

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 10.8

ph-index = 4

Forward Citations = 59(Granted Patents)


Location History:

  • Spring House, PA (US) (2015)
  • Wynnewood, PA (US) (2010 - 2019)

Company Filing History:


Years Active: 2010-2019

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Roberta Lamb: A Pioneer in ST2L Antagonist Research

Introduction

Roberta Lamb, an innovative inventor based in Wynnewood, PA, has made significant contributions to the field of pharmaceutical research. With a remarkable portfolio that includes six patents, her work primarily focuses on ST2L antagonists, which have the potential to impact various medical treatments.

Latest Patents

Roberta's latest patents include advancements in ST2L antagonists and their methods of use. These inventions involve novel polynucleotides that encode the antagonists or fragments thereof, along with detailed methods of making and utilizing these compounds. The innovations brought forth in these patents showcase her dedication to enhancing therapeutic options for patients.

Career Highlights

Throughout her career, Roberta has worked with reputable organizations, including Janssen Biotech, Inc. Her experience at such prominent institutions underscores her expertise in the field and her commitment to advancing scientific knowledge.

Collaborations

Roberta has collaborated with talented individuals such as Karen Duffy and Natalie Fursov. These partnerships have enabled her to explore various facets of research and development, further enriching her contributions to the scientific community.

Conclusion

Roberta Lamb's innovative spirit and unwavering commitment to research are evident in her impressive patent portfolio. As she continues to explore the potential of ST2L antagonists, her work promises to leave a lasting impact on the pharmaceutical industry and improve the lives of many.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…